Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

Mise à jour : Il y a 6 ans
Référence : NCT00322517

Femme Homme

Extrait

To determine the antitumor efficacy and the safety of SU-014813 at a dose of 100 mg orally once daily in patients with Metastatic Breast Cancer


Critère d'inclusion

  • Breast Neoplasms


Liens